Showing 181 - 190 of 832,425
Persistent link: https://www.econbiz.de/10012439514
This working paper critically examines the pharmaceutical industry and the incentive argument in patent law. It begins by framing an overview of the industry and patent law, focusing on U.S. and U.K. law, and multilateral agreements, and efforts by international organizations, such as the World...
Persistent link: https://www.econbiz.de/10014077712
We show how characterizing optimal patent policy for the pharmaceutical industry only requires information about generic producers' responses to changes in the effective duration and scope of new drug patents. To estimate these responses, we use data on Paragraph IV patent challenges, and two...
Persistent link: https://www.econbiz.de/10014097057
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...
Persistent link: https://www.econbiz.de/10013405463
Persistent link: https://www.econbiz.de/10014474366
Persistent link: https://www.econbiz.de/10003377450
-claims analysis, stochastic game theory, as well as novel numerical methods. The text re-initiates a discussion about the contribution … contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent … advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a …
Persistent link: https://www.econbiz.de/10013520747
Persistent link: https://www.econbiz.de/10014631382
Persistent link: https://www.econbiz.de/10012314136
We study the role of firm heterogeneity and imperfect competition for global production networks and the gains from trade. We develop a quantifiable trade model with two-sided firm heterogeneity, matching frictions, and oligopolistic competition upstream. More productive buyers endogenously...
Persistent link: https://www.econbiz.de/10015051741